| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/01/1992 | EP0492369A1 Novel amino and nitro containing tricyclic compounds useful as inhibitors of ace |
| 07/01/1992 | EP0492247A1 Effervescent H2 blocker formulation |
| 07/01/1992 | EP0492179A2 Avian growth hormone receptor and binding protein |
| 07/01/1992 | EP0492178A2 Naphthoic acid derivative |
| 07/01/1992 | EP0492136A2 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 07/01/1992 | EP0492105A2 Treatment of cardiac hypertrophy with angiotensin-II-receptor-blockers |
| 07/01/1992 | EP0491849A1 A method for the purification of transforming growth factor (tgf-). |
| 07/01/1992 | EP0491770A1 Substituted urea compounds and their preparation and use |
| 07/01/1992 | CN1062289A Process for treating cardiovascular hypertrophy and hyperplasia |
| 07/01/1992 | CN1017242B New quianzoline derivatives and process for their production |
| 07/01/1992 | CA2058563A1 4-(4-imidazolyl) piperidines substituted at position 1, their preparation and also their therapeutic applications |
| 06/30/1992 | US5126488 2β,19-methyleneamino bridged steroids as aromatase inhibitors |
| 06/30/1992 | US5126365 Bicyclic derivatives |
| 06/30/1992 | US5126363 Central nervous system disorders |
| 06/30/1992 | US5126354 Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivatives |
| 06/30/1992 | US5126344 Diazine derivatives and pharmaceutical use |
| 06/30/1992 | US5126342 Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| 06/30/1992 | US5126326 Enzyme inhibiting peptide derivatives |
| 06/30/1992 | US5126324 Method of enhancing growth in patients using combination therapy |
| 06/30/1992 | US5126135 Dermatological composition based on an aqueous phase |
| 06/30/1992 | CA1304391C Lipoxygenase inhibiting compounds |
| 06/29/1992 | WO1992012177A1 Novel megakaryocyte amplifier and production thereof |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2073177A1 Megakaryocyte potentiator and method for producing the same |
| 06/29/1992 | CA2058351A1 Avian growth hormone receptor and binding protein |
| 06/27/1992 | CA2058086A1 Hair growth stimulator |
| 06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
| 06/25/1992 | WO1992010567A1 Synthetic bioadhesive polypeptide |
| 06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
| 06/25/1992 | WO1992010510A1 Dithiolano- and dithianoglycin-containing renin-inhibiting peptides, process for producing the same and their use in medicaments |
| 06/25/1992 | WO1992010509A1 Renin-inhibiting peptides of the cyclohexylstatin type, process for producing the same and their use in medicaments |
| 06/25/1992 | WO1992010498A1 Novel csaids |
| 06/25/1992 | WO1992010468A1 Anti-atherosclerotic aryl compounds |
| 06/25/1992 | WO1992010195A1 Cell proliferation matrix and use thereof |
| 06/25/1992 | WO1992010192A1 Indan derivatives |
| 06/25/1992 | WO1992010189A1 Imidazolyl-alkenoic acids |
| 06/25/1992 | WO1992010188A1 Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke |
| 06/25/1992 | WO1992010187A1 Use of angiotensin ii antagonists in the treatment of angina pectoris |
| 06/25/1992 | WO1992010186A1 Use of angiotensn ii receptor antagonists for the preparation of a medicament for improving cognitive function |
| 06/25/1992 | WO1992010185A1 Use of angiotensin ii receptor antagonists in the prevention of restinosis |
| 06/25/1992 | WO1992010184A1 Use of angiotensin ii receptor antagonists in the treatment of atheroma |
| 06/25/1992 | WO1992010183A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
| 06/25/1992 | WO1992010182A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 06/25/1992 | WO1992010181A1 Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy |
| 06/25/1992 | WO1992010180A1 Use of angiotensin ii antagonist in the treatment of infarction |
| 06/25/1992 | WO1992010179A1 Use of angiotensin ii receptor antagonists in the treatment of macular degeneration |
| 06/25/1992 | WO1992010097A1 Angiotensin ii receptor blocking compositions |
| 06/25/1992 | WO1992009586A1 Active oxygen inhibitor |
| 06/25/1992 | CA2097181A1 Cell proliferation matrix and use thereof |
| 06/24/1992 | EP0491664A1 Serotonin antagonists |
| 06/24/1992 | EP0491586A1 Use in anaesthesia and pharmaceutical compositions of (S)-isoflurane and (S)-desflurane |
| 06/24/1992 | EP0491549A1 Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 06/24/1992 | EP0491361A2 Short peptides having the effect of insulin |
| 06/24/1992 | EP0491114A1 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity |
| 06/24/1992 | EP0490919A1 Cytoprotective fatty moiety compounds |
| 06/24/1992 | CN1062145A Azasteroid compounds for treatment of prostatic hypertrophy, their preparation and use |
| 06/24/1992 | CN1062143A Condensed heterocyclic compouds, their production and use |
| 06/24/1992 | CN1062138A Synergism of hiv reverse transcriptase inhibitors |
| 06/23/1992 | US5124473 Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same |
| 06/23/1992 | US5124455 Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
| 06/23/1992 | US5124360 Administering D-chiroinositol to achieve reduction in blood glucose level |
| 06/23/1992 | US5124350 Leukotriene b4 antagonists |
| 06/23/1992 | US5124346 Synergistic combinations in the treatment of anxiety |
| 06/23/1992 | US5124342 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
| 06/23/1992 | US5124336 Azabenzimidazole derivatives which are thromboxane receptor antagonists |
| 06/23/1992 | US5124335 Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | US5124147 Mixture of antagonist to platelet activating factor and antibody |
| 06/23/1992 | CA1304086C Guanidine carboxylic acid esters, processes for their preparation and pharmaceutical preparations containing these compounds |
| 06/23/1992 | CA1303996C Methods for treatment of sundamaged human skin with retinoids |
| 06/23/1992 | CA1303994C2 Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds |
| 06/22/1992 | WO1992011021A1 Angiogenic peptides |
| 06/22/1992 | CA2058258A1 Substituted benzene derivatives for use in the treatment of glaucoma |
| 06/22/1992 | CA2058178A1 Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
| 06/22/1992 | CA2058168A1 New use of peptide derivative |
| 06/22/1992 | CA2055984A1 Synergistic effect of lantibiotics in combination with selected agents against gram negative bacteria |
| 06/22/1992 | CA2055661A1 Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation |
| 06/21/1992 | WO1992011268A1 Novel methylenebisphosphonic acid derivatives |
| 06/21/1992 | CA2098734A1 Novel mrthylenebisphosphonic acid derivatives |
| 06/21/1992 | CA2057972A1 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 06/20/1992 | WO1992011259A1 Azabicyclic amides or esters of halogenated benzoic acids |
| 06/20/1992 | WO1992011037A2 Targeting of therapeutic agents using polysaccharides |
| 06/20/1992 | CA2098729A1 Azabicyclic amides or esters of halogenated benzoic acids |
| 06/19/1992 | WO1992011360A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/19/1992 | CA2098484A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/19/1992 | CA2057829A1 15-nitro-2beta,3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydro tabersonine derivatives, pharmaceutical compositions containing them andprocess for preparing same |
| 06/19/1992 | CA2057391A1 Serotonin antagonists |
| 06/18/1992 | WO1992011035A1 Improved treatment method for cancer |
| 06/17/1992 | EP0490820A2 Biphenylyl compounds |
| 06/17/1992 | EP0490818A1 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof |
| 06/17/1992 | EP0490816A2 Fluoro-compounds |
| 06/17/1992 | EP0490772A1 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them |
| 06/17/1992 | EP0490590A1 New benzodiazepine analogs |
| 06/17/1992 | EP0490587A1 Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin II antagonists |
| 06/17/1992 | EP0490561A2 Nutrition |
| 06/17/1992 | EP0490380A2 Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent |
| 06/17/1992 | EP0490250A2 Use of interferon and an antimalarial agent for the treatment of malarial infections |
| 06/17/1992 | EP0489831A1 Substituted quinolines, their preparation and their use as lipoxygenase inhibitors and/or leukotriene antagonists |
| 06/17/1992 | CN1061974A 2beta, 19-ethylene bridged steroids as aromatase inhibitors |